FDA committee rejects two IQOS MRTP claims, approves one

Agency’s science committee agrees that PMI product decreases exposure to dangerous chemicals, but won’t accept broader claims of long-term risk reduction...
Unlock access

Want the full analysis? Let's talk

We share insights with professionals we’re in contact with. Let us know a bit about your interest.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*

Want the full analysis? Let's talk

We share insights with professionals we’re in contact with. Let us know a bit about your interest.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*